CytomX (CTMX) 2025 Earnings Outlook for Investors Worldwide
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
Apply temporary budget tweaks to handle short-term shifts. Explore flexible options that protect essentials while reducing non-essentials.
14,196 articlesCytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
A 59-year-old with $2.4 million saved faces a six-year funding gap before Medicare. The right tax-efficient strategy ...
SpaceX priced its IPO at a fixed $135 per share, aiming to raise roughly $75 billion and valuing the company around $...
Achieve broadens its fixed-rate HELOC, boosting the loan cap to $700,000 and offering lower rates for qualified borro...
The Yeatman Group closed 747 transaction sides in 2025, fueling rapid growth and a top-30 ranking in The Thousand, si...
FedEx recently spun off its FedEx Freight unit, creating two focused companies. This article explains what that move ...
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
A flood of AI-focused stock offerings could add trillions in market value and test whether buyers can keep up with ne...
Strategy shareholders approved a plan to start semi-monthly dividends on STRC preferred stock, aiming to steady price...
Marvell Technology jumped on news it will join the S&P 500, triggering bullish moves in chips and AI infrastructure p...
A federally funded health study tied to the Biden administration finds no safe level of alcohol and warns risks rise ...
A landmark move by the European Commission forces Meta to open WhatsApp to rival AI chatbots. The order could reshape...